FRUSCIO ROBERT
Publications
Bianchi, T., Grassi, T., Bazzurini, L., Testa, F., Corti, J., Pecis Cavagna, G., et al. (2024). The paradigm shift in advanced ovarian cancer: Outcomes of extensive primary cytoreductive surgery. A single-center retrospective analysis. EUROPEAN JOURNAL OF SURGICAL ONCOLOGY, 50(9 (September 2024)) [10.1016/j.ejso.2024.108523]. Detail
Marchetti, C., Ataseven, B., Perrone, A., Cassani, C., Fruscio, R., Sassu, C., et al. (2024). Clinical characteristics and survival outcome of early-stage, high-grade, serous tubo-ovarian carcinoma according to BRCA mutational status. GYNECOLOGIC ONCOLOGY, 187(August 2024), 170-177 [10.1016/j.ygyno.2024.05.008]. Detail
Heremans, R., Wynants, L., Valentin, L., Leone, F., Pascual, M., Fruscio, R., et al. (2024). Estimating risk of endometrial malignancy and other intracavitary uterine pathology in women without abnormal uterine bleeding using IETA-1 multinomial regression model: validation study. ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 63(4 (April 2024)), 556-563 [10.1002/uog.27530]. Detail
Marino, G., Grassi, T., De Ponti, E., Testa, F., Negri, S., Giuliani, D., et al. (2024). Fertility outcomes in stage I ovarian immature teratomas. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 34(9), 1416-1422 [10.1136/ijgc-2024-005534]. Detail
Chiappa, M., Decio, A., Guarrera, L., Mengoli, I., Karki, A., Yemane, D., et al. (2024). Onvansertib treatment overcomes olaparib resistance in high-grade ovarian carcinomas. CELL DEATH & DISEASE, 15(7) [10.1038/s41419-024-06894-1]. Detail
Research projects
Awards
Editorial boards
- Direttore di rivista, collana editoriale, enciclopedia - WORLD JOURNAL OF CLINICAL ONCOLOGY, 2015
- Direttore di rivista, collana editoriale, enciclopedia - ADVANCES IN THERAPY, 2011
- Direttore di rivista, collana editoriale, enciclopedia - BMC CANCER, 2010
Research and teaching assignments
- Professore a contratto - Professore a contratto di Anatomia nel corso di Laurea per Ostetriche - Università degli Studi di MILANO-BICOCCA, 2011 - 2014